NovoCure's total assets for Q3 2025 were $0.00, a decrease of -100.00% from the previous quarter. NVCR total liabilities were $243.85M for the fiscal quarter, a -72.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.